Market Overview

UPDATE: Barrington Reiterates Outperform Rating, $650 PT on Intuitive Surgical

Related ISRG
Markets Mostly Higher As Earnings Season Continues To Impress
UPDATE: Morgan Stanley Initiates Coverage On Intuitive Surgical
Stocks Sell Off as Shift from Risk Persists (Fox Business)

In a report published Friday, Barrington reiterated its Outperform rating and $650.00 price target on Intuitive Surgical (NASDAQ: ISRG).

Barrington noted, “We are reiterating our OUTPERFORM rating and $650 price target following ISRG's Q4/12 earnings as we believe management will continue to execute on its significant market opportunities over the short and long term and will drive strong procedure growth/pricing power with new technologies in new procedures. We believe the short reports circulated recently are largely based on unfounded concerns and we expect the patient and hospital demand for da Vinci procedures to remain high in the face of the issues highlighted in those reports.”

Intuitive Surgical closed on Thursday at $576.07.

Posted-In: BarringtonAnalyst Color Reiteration Analyst Ratings

 

Most Popular

Related Articles (ISRG)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters